TuHURA BIOSCIENCES, INC./NV Increase (Decrease) in Operating Capital
TuHURA BIOSCIENCES, INC./NV (HURA) reported Increase (Decrease) in Operating Capital of $23.68 thousand for the 9-month period ending 2016-03-31, per its 10-Q filed 2016-05-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingCapital · last filed 2016-05-12
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in operating capital for the quarter ending 2016-03-31 was -$206.55K.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in operating capital for the quarter ending 2015-12-31 was -$157.83K, a 629.10% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in operating capital for the quarter ending 2015-09-30 was $388.06K.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in operating capital for the quarter ending 2015-06-30 was -$350.58K, a 435.36% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in operating capital for fiscal 2015 was -$526.55K, a 240.84% decline from fiscal 2014.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in operating capital for fiscal 2014 was $373.87K.
| Period end | Increase (Decrease) in Operating Capital 3 month | Increase (Decrease) in Operating Capital 3 month as first filed | Increase (Decrease) in Operating Capital 6 month | Increase (Decrease) in Operating Capital 9 month | Increase (Decrease) in Operating Capital 12 month | Increase (Decrease) in Operating Capital 14 month | Increase (Decrease) in Operating Capital 36 month | Increase (Decrease) in Operating Capital 42 month | Increase (Decrease) in Operating Capital 48 month |
|---|---|---|---|---|---|---|---|---|---|
| 2016-03-31 | -$206.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-12 | -$364.38K derived: sum of 2 quarters · filed 2016-05-12 | $23.68K 10-Q · filed 2016-05-12 | -$326.90K derived: sum of 4 quarters · filed 2016-05-12 | |||||
| 2015-12-31 | -$157.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-12 | $230.23K 10-Q · filed 2016-02-12 | -$120.35K derived: sum of 3 quarters · filed 2016-02-12 | -$227.74K derived: sum of 4 quarters · filed 2016-05-12 | |||||
| 2015-09-30 | $388.06K 10-Q · filed 2015-11-16 | $37.48K derived: sum of 2 quarters · filed 2015-11-16 | -$69.91K derived: sum of 3 quarters · filed 2016-05-12 | -$40.08K derived: sum of 4 quarters · filed 2016-05-12 | |||||
| 2015-06-30 | -$350.58K derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-16 | -$457.97K derived: sum of 2 quarters · filed 2016-05-12 | -$428.14K derived: sum of 3 quarters · filed 2016-05-12 | -$526.55K 10-K · filed 2015-11-16 | |||||
| 2015-03-31 | -$107.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-12 | -$77.56K derived: sum of 2 quarters · filed 2016-05-12 | -$175.97K 10-Q · filed 2016-05-12 | -$71.42K derived: sum of 4 quarters · filed 2016-05-12 | |||||
| 2014-12-31 | $29.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-12 | -$68.58K 10-Q · filed 2016-02-12 | $35.96K derived: sum of 3 quarters · filed 2016-02-12 | $128.63K derived: sum of 4 quarters · filed 2016-02-12 | |||||
| 2014-09-30 | -$98.41K 10-Q · filed 2015-11-16 | $98.41K 10-Q · filed 2014-11-07 | $6.13K derived: sum of 2 quarters · filed 2015-11-16 | $98.80K derived: sum of 3 quarters · filed 2015-11-16 | $669.28K derived: sum of 4 quarters · filed 2015-11-16 | ||||
| 2014-06-30 | $104.54K derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-16 | $197.21K derived: sum of 2 quarters · filed 2015-11-16 | $767.69K derived: sum of 3 quarters · filed 2015-11-16 | $373.87K 10-K · filed 2015-11-16 | |||||
| 2014-03-31 | $92.67K 10-Q · filed 2014-05-15 | $663.15K derived: sum of 2 quarters · filed 2015-02-12 | $269.32K 10-Q · filed 2015-05-15 | $169.66K derived: sum of 4 quarters · filed 2015-02-12 | $387.13K 10-Q · filed 2014-05-15 | ||||
| 2013-12-31 | $570.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-12 | $361.99K 10-Q · filed 2015-02-12 | $77.00K derived: sum of 3 quarters · filed 2015-02-12 | -$259.59K derived: sum of 4 quarters · filed 2015-02-12 | |||||
| 2013-09-30 | -$208.50K 10-Q · filed 2014-11-07 | -$493.49K derived: sum of 2 quarters · filed 2014-11-07 | -$830.08K 10-Q · filed 2013-11-08 | $447.95K 10-Q · filed 2013-11-08 | |||||
| 2013-06-30 | -$285.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | -$621.58K 10-Q · filed 2013-08-12 | $656.45K 10-Q · filed 2013-08-12 | ||||||
| 2013-03-31 | -$336.59K 10-Q · filed 2014-05-15 | $941.45K 10-Q · filed 2013-05-15 | |||||||
| 2012-09-30 | $121.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $146.12K derived: sum of 2 quarters · filed 2013-11-08 | $126.80K 10-Q · filed 2013-11-08 | ||||||
| 2012-06-30 | $24.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $5.20K 10-Q · filed 2013-08-12 | |||||||
| 2012-03-31 | -$19.32K 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |